ARCHIVES

DRCCA Bard Group Recommends No New Nationwide Screening Program Until More Research Is Done

This article is from The Cancer Letter archive.

Vol. 08 No. 43 | November 5, 1982

Download PDF Visit The Full Archive

Related Articles

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

February 29, 2008

Gene Patterns Predict Lymphoma Response To Treatment

June 28, 2002

ACS Research Budget Over $82 Million

July 17, 1987

Blochs Plan To Fund National Network Of “Cancer Survivor Parks” In Every City

August 3, 1990

DCT Board Approves Concept Of Contract Recompetitions Worth $5.1 Million A Year

July 10, 1981

NCI Cooperative Group Clinical Trials Approved

April 30, 2010